Dyspnea Self-Management: Internet or Face-to-Face

呼吸困难自我管理:互联网或面对面

基本信息

项目摘要

Dyspnea or shortness of breath is the most common disabling symptom in patients with chronic obstructive pulmonary disease (COPD). The increased availability and growing acceptance of emerging technologies as a channel for health communication has opened up opportunities to provide convenient and seamless support for self-management of dyspnea and related symptoms to greater numbers of individuals. The overall goal of this proposal is to compare the impact of a new Internet dyspnea self-management program (i-DSMP) with a face-to-face program (f-DSMP) that has been shown to be effective in patients with COPD. It is hypothesized that there will be no significant differences between the i-DSMP and the f-DSMP in the primary outcomes of dyspnea with ADL, pulmonary exacerbations, exercise performance and adherence secondary outcomes of perception of social support, self-efficacy for managing dyspnea exercise, health resource utilization, and satisfaction with program at 3,6, and 12 months. Secondary aims are to relate subject usage patterns and satisfaction to changes in outcomes and to describe changes in symptom clusters and exercise patterns before, during and after acute exacerbations. Subjects with COPD who are currently using the Internet (N= 200) will be randomized to i-DSMP, f-DSMP, or Attention Control. Guided by physiological concepts, Social Cognitive Theory, and the Transtheoretical Model, the programs include: 1) initial face-to-face dyspnea interview and exercise consultation, 2) dyspnea education, 3) individualized exercise program, 4) self monitoring of exercise and symptoms, and 5) reminders and reinforcement of exercise. The i-DSMP will use online interactive learning modules, text chats, and bulletin board for communication and education and a wireless device (PDA) for monitoring symptoms, exercise, and to receive reinforcement for exercise. The f-DSMP will meet face-to-face, use written logs, and receive telephone reinforcement. If this i-DSMP is as effective as the f-DSMP, it will represent a first step in establishing an evidence-base for widespread implementation of self-management programs for people with symptoms of chronic illness using the Internet and mobile environments.
呼吸困难或呼吸短促是慢性阻塞性肺疾病(COPD)患者最常见的致残症状。新兴技术作为健康传播渠道的可用性和接受度不断提高,为更多的人提供了方便和无缝的呼吸困难和相关症状自我管理支持的机会。本提案的总体目标是比较新的互联网呼吸困难自我管理计划(i-DSMP)与已被证明对COPD患者有效的面对面计划(f-DSMP)的影响。假设i-DSMP和f-DSMP在ADL呼吸困难、肺部恶化、运动表现和依从性等主要结局、社会支持感知、管理呼吸困难的自我效能感等次要结局方面没有显着差异。运动、卫生资源利用以及3、6和12个月时对计划的满意度。次要目的是将受试者使用模式和满意度与结局变化联系起来,并描述急性加重前、期间和之后症状群和运动模式的变化。目前正在使用互联网的COPD受试者(N= 200)将被随机分配至i-DSMP、f-DSMP或注意力控制组。以生理学概念、社会认知理论和跨理论模型为指导,这些方案包括:1)初始面对面呼吸困难访谈和运动咨询,2)呼吸困难教育,3)个体化运动方案,4)运动和症状的自我监测,5)运动的提醒和强化。i-DSMP将使用在线互动学习模块、文本聊天和公告板进行沟通和教育,并使用无线设备(PDA)监测症状、锻炼和接受锻炼强化。f-DSMP将进行面对面的会谈,使用书面记录,并接受电话增援。如果这个i-DSMP和f-DSMP一样有效,它将代表着为使用互联网和移动的环境的慢性病症状患者广泛实施自我管理计划建立证据基础的第一步。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

VIRGINIA Lee CARRIERI-KOHLMAN其他文献

VIRGINIA Lee CARRIERI-KOHLMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('VIRGINIA Lee CARRIERI-KOHLMAN', 18)}}的其他基金

EFFICACY OF YOGA FOR SELF-MANAGEMENT OF DYSPNEA IN COPD
瑜伽对慢性阻塞性肺病患者呼吸困难自我管理的功效
  • 批准号:
    7202638
  • 财政年份:
    2005
  • 资助金额:
    $ 46.31万
  • 项目类别:
Dyspnea Self-Management: Internet or Face-to-Face
呼吸困难自我管理:互联网或面对面
  • 批准号:
    7846883
  • 财政年份:
    2005
  • 资助金额:
    $ 46.31万
  • 项目类别:
Dyspnea Self-Management: Internet or Face-to-Face
呼吸困难自我管理:互联网或面对面
  • 批准号:
    7116314
  • 财政年份:
    2005
  • 资助金额:
    $ 46.31万
  • 项目类别:
Dyspnea Self-Management: Internet or Face-to-Face
呼吸困难自我管理:互联网或面对面
  • 批准号:
    7246560
  • 财政年份:
    2005
  • 资助金额:
    $ 46.31万
  • 项目类别:
Dyspnea Self-Management: Internet or Face-to-Face
呼吸困难自我管理:互联网或面对面
  • 批准号:
    7626036
  • 财政年份:
    2005
  • 资助金额:
    $ 46.31万
  • 项目类别:
Efficacy of Yoga for Self-Management of Dyspnea in COPD
瑜伽对慢性阻塞性肺病患者呼吸困难自我管理的功效
  • 批准号:
    6972296
  • 财政年份:
    2004
  • 资助金额:
    $ 46.31万
  • 项目类别:
Efficacy of Yoga for Self-Management of Dyspnea in COPD
瑜伽对慢性阻塞性肺病患者呼吸困难自我管理的功效
  • 批准号:
    6656900
  • 财政年份:
    2002
  • 资助金额:
    $ 46.31万
  • 项目类别:
Efficacy of Yoga for Self-Management of Dyspnea in COPD
瑜伽对慢性阻塞性肺病患者呼吸困难自我管理的功效
  • 批准号:
    6506631
  • 财政年份:
    2002
  • 资助金额:
    $ 46.31万
  • 项目类别:
TREATMENTS FOR DYSPNEA--EDUCATION, EXPOSURE OR TRAINING
呼吸困难的治疗——教育、暴露或培训
  • 批准号:
    2873103
  • 财政年份:
    1995
  • 资助金额:
    $ 46.31万
  • 项目类别:
TREATMENTS FOR DYSPNEA--EDUCATION, EXPOSURE OR TRAINING
呼吸困难的治疗——教育、暴露或培训
  • 批准号:
    2655408
  • 财政年份:
    1995
  • 资助金额:
    $ 46.31万
  • 项目类别:

相似海外基金

ARE COMMONLY USED CARDIOVASCULAR RISK SCORING TOOLS RELIABLE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)?
常用的心血管风险评分工具对于慢性阻塞性肺疾病 (COPD) 患者可靠吗?
  • 批准号:
    493118
  • 财政年份:
    2023
  • 资助金额:
    $ 46.31万
  • 项目类别:
Decoding how the aryl hydrocarbon receptor (AhR) controls cigarette smoke-induced lung inflammation and development of chronic obstructive pulmonary disease (COPD)
解读芳烃受体 (AhR) 如何控制香烟烟雾引起的肺部炎症和慢性阻塞性肺病 (COPD) 的发展
  • 批准号:
    487508
  • 财政年份:
    2023
  • 资助金额:
    $ 46.31万
  • 项目类别:
    Operating Grants
The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)
腺嘌呤核苷酸转位酶在慢性阻塞性肺病(COPD)线粒体功能相关衰老中的作用
  • 批准号:
    10633608
  • 财政年份:
    2023
  • 资助金额:
    $ 46.31万
  • 项目类别:
Optimisation of precision therapy for chronic obstructive pulmonary disease: A dynamic treatment regime analysis
慢性阻塞性肺疾病精准治疗优化:动态治疗方案分析
  • 批准号:
    489950
  • 财政年份:
    2023
  • 资助金额:
    $ 46.31万
  • 项目类别:
    Operating Grants
Elucidation of the mechanism of sarcopenia associated with chronic obstructive pulmonary disease
阐明肌肉减少症与慢性阻塞性肺疾病相关的机制
  • 批准号:
    23K15702
  • 财政年份:
    2023
  • 资助金额:
    $ 46.31万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Risk factors for chronic obstructive pulmonary disease exacerbations, quality of care, and outcomes in people with HIV
HIV 感染者慢性阻塞性肺病恶化的危险因素、护理质量和结果
  • 批准号:
    10700228
  • 财政年份:
    2023
  • 资助金额:
    $ 46.31万
  • 项目类别:
Impaired Pneumococcal Antibody Function and Exacerbations of Chronic Obstructive Pulmonary Disease
肺炎球菌抗体功能受损和慢性阻塞性肺疾病恶化
  • 批准号:
    10543560
  • 财政年份:
    2022
  • 资助金额:
    $ 46.31万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测
  • 批准号:
    10445739
  • 财政年份:
    2022
  • 资助金额:
    $ 46.31万
  • 项目类别:
Multi-omic Risk Prediction of Chronic Obstructive Pulmonary Disease in European- and African-Ancestry Populations_Supplement
欧洲和非洲血统人群慢性阻塞性肺疾病的多组学风险预测_补充
  • 批准号:
    10772527
  • 财政年份:
    2022
  • 资助金额:
    $ 46.31万
  • 项目类别:
Pulmonary Vascular Disease as a Contributor to Respiratory Morbidity in Chronic Obstructive Pulmonary Disease
肺血管疾病是慢性阻塞性肺疾病呼吸系统疾病发病的一个原因
  • 批准号:
    10449417
  • 财政年份:
    2022
  • 资助金额:
    $ 46.31万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了